Microbiota-host genetic interactions modulate MASLD risk in PNPLA3(I148M) carriers via ceramides and are reversible by targeted microbial interventions.

Disruption of the gut barrier amplifies PNPLA3 I148M-related liver injury, with ceramide levels increasing by 2- to 3-fold in a mouse model of MASLD.

• Why it matters: Understanding how genetic susceptibility interacts with environmental factors like gut health is crucial for preventing severe liver disease in at-risk populations.
• What they did: Researchers used a dual-hit mouse model combining hepatic Pnpla3 I148M expression and Nlrp6 deficiency, along with multi-omics profiling and human cohort analysis, to explore microbiota-host interactions.
• The result: Restoring a healthy microbiota through fecal transplants or targeted microbial proteins improved gut integrity and reduced liver fat, highlighting microbiota modulation as a promising intervention for MASLD.